JOHN R CIOTTI

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TAMPA, FL NPI 1992186985

General Payments — all program years on this page

$22,210.72

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,748.90 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,410.9018
Consulting Fee $338.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $493.325
2019 $779.0512
2020 $151.153
2021 $5,745.0610
2022 $8,873.7815
2023 $4,419.4624
2024 $1,748.9019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086619487 Novartis Pharmaceuticals Corporation $32.99 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086619515 Novartis Pharmaceuticals Corporation $62.78 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086619551 Novartis Pharmaceuticals Corporation $19.30 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093917846 Alexion Pharmaceuticals, Inc. $32.83 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093996785 Alexion Pharmaceuticals, Inc. $124.95 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101182586 Celgene Corporation $31.52 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101757705 E.R. Squibb & Sons, L.L.C. $440.01 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111550678 Amgen Inc. $29.80 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111550680 Amgen Inc. $30.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120246877 EMD Serono, Inc. $34.17 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133036862 Genentech, Inc. $27.60 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874761 TG Therapeutics, Inc. $73.92 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874763 TG Therapeutics, Inc. $338.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136874767 TG Therapeutics, Inc. $30.37 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874847 TG Therapeutics, Inc. $40.22 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139905796 GENZYME CORPORATION $141.96 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139905848 GENZYME CORPORATION $134.01 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139905868 GENZYME CORPORATION $108.77 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139905914 GENZYME CORPORATION $15.23 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.